01
Continuous monitoring
Intermittent tests can miss rapid biomarker changes. We develop stable aptamer-based sensors and microneedle platforms to track drugs and biomarkers continuously, supporting timely, personalised treatment.
We develop sensitive, stable biosensors for molecular diagnostics and continuous health monitoring, integrating electrochemical interfaces with microfluidics.

Intermittent tests can miss rapid biomarker changes. We develop stable aptamer-based sensors and microneedle platforms to track drugs and biomarkers continuously, supporting timely, personalised treatment.
Laboratory tests offer limited insight into daily health changes. We integrate electrochemical sensors into wearable platforms to enable accessible monitoring beyond the lab.
Early detection requires reliable measurement of scarce targets. We integrate biosensors, microfluidics and CRISPR assays for sensitive molecular analysis.